Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

OHR Pharmaceutical, Inc.

NASDAQ: OHRPHealthcare / Biotechnology / USA
0.140000.00Vol 31 2241Y Perf -91.11%
Dec 13th, 2018 10:07
BID0.1300 ASK0.1400
Open0.1300 Previous Close0.1300
Pre-Market- After-Trading-
 - -%  - -%
Target Price
0.40 
Analyst Rating
— 0.00
Potencial %
207.69 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.97 
Earnings Date
21st Dec 2018

Today's Price Range

0.13000.1400

 

52wk Range

0.12002.18

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-35.00%
3 Months
-27.78%
6 Months
-50.00%
1 Year
-91.11%
3 Years
-96.86%
5 Years
-98.37%

Quotes

Name / TickerPriceChg.Chg.%
OHRP0.14000.00000.00
AAPL171.692.59001.53
GOOG1 073.679.99000.94
MSFT110.321.24001.14
XOM76.640.62000.82
WFC47.54-0.2000-0.42
JNJ148.261.16000.79
FB144.960.46000.32
GE7.380.67009.99
JPM101.230.21000.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.00
Current Ratio
5.50
Long Term Debt to Total Capital
-
Total Debt to Equity
0.01
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.46
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.90
Cash Flow Per Share
-0.25
Price to Tangible Book
1.99
Book Value per Share
0.30
Enterprise Value (in ths.)
3 651
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-71.02
ROE last 12 Months
-53.70
Return on Assets (5Y Avg)
-61.49
ROA last 12 Months
-46.83
Return on Capital (5Y Avg)
-75.09
ROC last 12 Months
-53.30
Return on invested Capital Q
-3.09
Return on invested Capital Y
-99.21
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.05-
Q01 2018--0.07-
Q04 2017-0.08-0.080.00
Q03 2017-0.25-0.0772.00
Q02 2017-0.30-0.2130.00
Q01 2017-0.19-0.21-10.53
Q04 2016-0.24-0.2112.50
Q03 2016-0.23-0.24-4.35
Earnings Per EndEstimateRevision %Trend
12/2017 QR-0.0795.48Positive
3/2018 QR-0.07--
9/2018 FY-0.52--
9/2019 FY-0.810.00-
Next Report Date21st Dec 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume31 224
Shares Outstanding (in ths.)56 470
Trades Count56
Dollar Volume5 919
Avg. Volume1 151 946
Avg. Weekly Volume351 663
Avg. Monthly Volume490 426
Avg. Quarterly Volume1 012 010

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

68%32%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News